Abstract:Objective This meta-analysis attempted to derive pooled estimates for the associations between various cardiovascular-renal disorders and the deletion/insertion (D/I) polymorphism of the angiotensin converting enzyme (ACE) gene.Methods Case-control studies were combined, using the Mantel-Haenszel approach. Joint P values for continuous variables were calculated by Stouffer's method. Continuous measurements reported in different units were expressed on a percentage scale using the within-study mean of the II genotype as the denominator.Results The computerized database used for this analysis included 145 reports with an overall sample size of 49 959 subjects. Overall, possession of the D allele was associated with an increased risk of atherosclerotic and renal microvascular complications. In comparison with the II reference group, the excess risk in DD homozygotes (P < 0.001) was 32% for coronary heart disease (CHD; 30 studies), 45% for myocardial infarction (20 studies), 94% for stroke (five studies) and 56% for diabetic nephropathy (11 studies). The corresponding risk in DI heterozygotes amounted to 11% (P = 0.02), 13% (P = 0.02), 22% (P = 0.10) and 40% (P < 0.001), respectively. Hypertension (23 studies), left ventricular hypertrophy (five studies), hypertrophic or dilated cardiomyopathy (eight studies) and diabetic retinopathy (two studies) were not related to the DI polymorphism. Publication bias was observed for CHD, myocardial infarction and microvascular nephropathy, but not hypertension. In studies with DNA amplification in the presence of insertion-specific primers, the risk associated with the DD genotype increased to 150% [95% confidence interval (CI) 76-256; four studies] for diabetic nephropathy, but decreased to 12% (95% CI -3 to 28; seven studies) for CHD and 14% (95% CI -6 to 37; four studies) for myocardial infarction. On the other hand, the pooled odds ratios did not materially change if the metaanalysis was limited to articles published in journals with an impact factor of at least 4. Furthermore, compared with the II control group, the circulating ACE levels (29 studies) were raised 58 and 31% (P < 0.001) in DD and DI subjects, respectively. In contrast, plasma renin (10 studies), systolic and diastolic blood pressure (46 studies) and body mass index (30 studies) were not associated with the D allele.Conclusion The D allele is not associated with hypertension, but behaves as a marker of atherosclerotic cardiovascular complications and diabetic nephropathy. These associations do not necessarily imply a causal relationship and may have been inflated by publication bias. Nevertheless, their possible therapeutic implications may be subject to further investigation in prospective (intervention) studies. (C) Rapid Science Publishers ISSN 0263-6352.

Protective effects of angiotensin-converting enzyme I/I and matrix metalloproteinase-3 6A/6A polymorphisms on dilatative pathology within the ascending thoracic aorta

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-9 Gene (−8202A-->G) is Associated with Thoracic Aortic Aneurysms and Dissection

Genetic Polymorphisms of MMP1, MMP9, COL1A1, and COL1A2 in Polish Patients with Thoracic Aortopathy

Meta-analysis of the association between angiotensin-converting enzyme I/D polymorphism and aortic aneurysm risk.

Variations in Matrix Metalloproteinase-1, -3, and -9 Genes and the Risk of Acute Coronary Syndrome and Coronary Artery Disease in the Chinese Han Population.

Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis

Impact Of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms On Dilated Cardiomyopathy And Hypertrophic Cardiomyopathy Risk

Extracellular matrix metalloproteinase inducer (EMMPRIN) is present in smooth muscle cells of human aneurysmal aorta and is induced by angiotensin II in vitro.

The Deletion/insertion Polymorphism of the Angiotensin Converting Enzyme Gene and Cardiovascular-Renal Risk.

MMP-2 gene polymorphisms are associated with type A aortic dissection and aortic diameters in patients.

The polymorphisms in angiotensin-converting enzyme and angiotensin-converting enzyme 2 are not associated with thoracic aortic diseases and coronary heart disease

Angiotensin-converting Enzyme I/D Polymorphism and the Risk of Thoracic Aortic Dissection in Chinese Han Population

Relationship between matrix metalloproteinases-9 gene polymorphism and the cardiovascular remodeling in hypertension patients

Abstract 311: the Role of ADAMTS-5 in Aortic Dilatation and Extracellular Matrix Remodeling

Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome Polymorphisms : FromGly 460 Trp-Adducin α and I / DAngiotensin-Converting Enzyme

Role of ADAMTS-5 in Aortic Dilatation and Extracellular Matrix Remodeling

Angiotensin-Converting Enzyme I/D and Alpha-Adducin Gly460trp Polymorphisms - from Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome

Matrix metalloproteinases in ascending aortic aneurysms: Bicuspid versus trileaflet aortic valves1

Association of Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism with the Risk of Atherosclerosis.

Divergent Roles of Matrix Metalloproteinase 2 in Pathogenesis of Thoracic Aortic Aneurysm

Singular and epistatic effects of three candidate genes on carotid and femoral intima-media thickness in a Caucasian population